These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 21472826

  • 1. Immunogenicity and safety of influenza vaccination in children with inflammatory bowel disease.
    deBruyn JC, Hilsden R, Fonseca K, Russell ML, Kaplan GG, Vanderkooi O, Wrobel I.
    Inflamm Bowel Dis; 2012 Jan; 18(1):25-33. PubMed ID: 21472826
    [Abstract] [Full Text] [Related]

  • 2. Immunogenicity of Influenza Vaccine for Patients with Inflammatory Bowel Disease on Maintenance Infliximab Therapy: A Randomized Trial.
    deBruyn J, Fonseca K, Ghosh S, Panaccione R, Gasia MF, Ueno A, Kaplan GG, Seow CH, Wrobel I.
    Inflamm Bowel Dis; 2016 Mar; 22(3):638-47. PubMed ID: 26595551
    [Abstract] [Full Text] [Related]

  • 3. Immune response to influenza vaccine in children with inflammatory bowel disease.
    Lu Y, Jacobson DL, Ashworth LA, Grand RJ, Meyer AL, McNeal MM, Gregas MC, Burchett SK, Bousvaros A.
    Am J Gastroenterol; 2009 Feb; 104(2):444-53. PubMed ID: 19174786
    [Abstract] [Full Text] [Related]

  • 4. Immune response to influenza vaccine in pediatric patients with inflammatory bowel disease.
    Mamula P, Markowitz JE, Piccoli DA, Klimov A, Cohen L, Baldassano RN.
    Clin Gastroenterol Hepatol; 2007 Jul; 5(7):851-6. PubMed ID: 17544875
    [Abstract] [Full Text] [Related]

  • 5. Immunogenicity of High Dose Influenza Vaccine for Patients with Inflammatory Bowel Disease on Anti-TNF Monotherapy: A Randomized Clinical Trial.
    Caldera F, Hillman L, Saha S, Wald A, Grimes I, Zhang Y, Sharpe AR, Reichelderfer M, Hayney MS.
    Inflamm Bowel Dis; 2020 Mar 04; 26(4):593-602. PubMed ID: 31504526
    [Abstract] [Full Text] [Related]

  • 6. Immunogenicity and Safety of Influenza Vaccine in Inflammatory Bowel Disease Patients Treated or not with Immunomodulators and/or Biologics: A Two-year Prospective Study.
    Launay O, Abitbol V, Krivine A, Slama LB, Bourreille A, Dupas JL, Hébuterne X, Savoye G, Deplanque D, Bouhnik Y, Pelletier AL, Galtier F, Laharie D, Nachury M, Zerbib F, Allez M, Bommelaer G, Duclos B, Lucht F, Gougeon ML, Tartour E, Rozenberg F, Hanslik T, Beaugerie L, Carrat F, MICIVAX Study Group.
    J Crohns Colitis; 2015 Dec 04; 9(12):1096-107. PubMed ID: 26351392
    [Abstract] [Full Text] [Related]

  • 7. The priming effect of previous natural pandemic H1N1 infection on the immunogenicity to subsequent 2010-2011 influenza vaccination in children: a prospective cohort study.
    Kang EK, Eun BW, Kim NH, Lim JS, Lee JA, Kim DH.
    BMC Infect Dis; 2016 Aug 22; 16(1):438. PubMed ID: 27549626
    [Abstract] [Full Text] [Related]

  • 8. Immunogenicity of a 2009 pandemic influenza virus A H1N1 vaccine, administered simultaneously with the seasonal influenza vaccine, in children receiving chemotherapy.
    Ottóffy G, Horváth P, Muth L, Sólyom A, Garami M, Kovács G, Nyári T, Molnár D, Pauler G, Jankovics I.
    Pediatr Blood Cancer; 2014 Jun 22; 61(6):1013-6. PubMed ID: 24395342
    [Abstract] [Full Text] [Related]

  • 9. Immunogenicity of Quadrivalent Influenza Vaccine for Patients with Inflammatory Bowel Disease Undergoing Immunosuppressive Therapy.
    Shirai S, Hara M, Sakata Y, Tsuruoka N, Yamamoto K, Shimoda R, Gomi Y, Yoshii H, Fujimoto K, Iwakiri R.
    Inflamm Bowel Dis; 2018 Apr 23; 24(5):1082-1091. PubMed ID: 29538682
    [Abstract] [Full Text] [Related]

  • 10. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB, Neuzil KM, Zhu Y, Fairchok MP, Gagliano ME, Monto AS, Englund JA.
    Pediatrics; 2006 Sep 23; 118(3):e570-8. PubMed ID: 16950948
    [Abstract] [Full Text] [Related]

  • 11. Immunogenicity and safety of an inactivated quadrivalent influenza vaccine in healthy adults: a phase II, open-label, uncontrolled trial in Japan.
    Tsurudome Y, Kimachi K, Okada Y, Matsuura K, Ooyama Y, Ibaragi K, Kino Y, Ueda K.
    Microbiol Immunol; 2015 Oct 23; 59(10):597-604. PubMed ID: 26272602
    [Abstract] [Full Text] [Related]

  • 12. Quadrivalent Influenza Vaccine-Induced Antibody Response and Influencing Determinants in Patients ≥ 55 Years of Age in the 2018/2019 Season.
    Ganczak M, Dubiel P, Drozd-Dąbrowska M, Hallmann-Szelińska E, Szymański K, Brydak LB.
    Int J Environ Res Public Health; 2019 Nov 14; 16(22):. PubMed ID: 31739554
    [Abstract] [Full Text] [Related]

  • 13. Hemagglutination inhibiting antibody persistence 1 year after influenza vaccination in Korean children and adolescents.
    Kang EK, Eun BW, Kim NH, Kim YK, Lim JS, Kim DH.
    Hum Vaccin Immunother; 2017 Apr 03; 13(4):895-902. PubMed ID: 27905835
    [Abstract] [Full Text] [Related]

  • 14. Infliximab and/or immunomodulators inhibit immune responses to trivalent influenza vaccination in adults with inflammatory bowel disease.
    Hagihara Y, Ohfuji S, Watanabe K, Yamagami H, Fukushima W, Maeda K, Kamata N, Sogawa M, Shiba M, Tanigawa T, Tominaga K, Watanabe T, Fujiwara Y, Hirota Y, Arakawa T.
    J Crohns Colitis; 2014 Mar 03; 8(3):223-33. PubMed ID: 24011513
    [Abstract] [Full Text] [Related]

  • 15. Vaccination against influenza in patients with systemic sclerosis.
    Litinsky I, Balbir A, Zisman D, Mandelboim M, Mendelson E, Feld J, Braun Y, Anouk M, Kaufman I, Paran D, Caspi D, Elkayam O.
    Clin Exp Rheumatol; 2012 Mar 03; 30(2 Suppl 71):S7-11. PubMed ID: 22409886
    [Abstract] [Full Text] [Related]

  • 16. Long-term immunogenicity of a virosomal subunit inactivated influenza vaccine in children with asthma.
    Zuccotti G, Amendola A, Viganò A, Pariani E, Zappa A, Pogliani L, Giacomet V, Savarino A, Podestà A, Rottoli A, Tanzi E, Zanetti A, Radaelli G.
    Vaccine; 2007 Sep 17; 25(37-38):6692-8. PubMed ID: 17697730
    [Abstract] [Full Text] [Related]

  • 17. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
    Englund JA, Walter EB, Gbadebo A, Monto AS, Zhu Y, Neuzil KM.
    Pediatrics; 2006 Sep 17; 118(3):e579-85. PubMed ID: 16950949
    [Abstract] [Full Text] [Related]

  • 18. Antibody and cell-mediated immune response to whole virion and split virion influenza vaccine in patients with inflammatory bowel disease on maintenance immunosuppressive and biological therapy.
    Bálint A, Farkas K, Éva PK, Terhes G, Urbán E, Szucs M, Nyári T, Bata Z, Nagy F, Szepes Z, Miheller P, Lorinczy K, Lakatos PL, Lovász B, Tamás S, Kulcsár A, Berényi A, Törocsik D, Daróczi T, Saródi Z, Wittmann T, Molnár T.
    Scand J Gastroenterol; 2015 Feb 17; 50(2):174-81. PubMed ID: 25384624
    [Abstract] [Full Text] [Related]

  • 19. Serological response to the 2009 H1N1 influenza vaccination in patients with inflammatory bowel disease.
    Cullen G, Bader C, Korzenik JR, Sands BE.
    Gut; 2012 Mar 17; 61(3):385-91. PubMed ID: 21757451
    [Abstract] [Full Text] [Related]

  • 20. Immune response to influenza vaccination in children with cancer.
    Doganis D, Kafasi A, Dana H, Spanakis N, Baka M, Pourtsidis A, Sdogou T, Vintila A, Rafailidou V, Chantzi P, Servitzoglou M, Bouhoutsou D, Varvoutsi M, Kosmidis H, Tsolia M.
    Hum Vaccin Immunother; 2018 Mar 17; 14(9):2310-2317. PubMed ID: 29708816
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.